A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the long-term ASP1941 safety evaluation in patients with type (Q37257445)
Jump to navigation
Jump to search
scientific article published on February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the long-term ASP1941 safety evaluation in patients with type |
scientific article published on February 2015 |
Statements
1 reference
A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the long-term ASP1941 safety evaluation in patients with type (English)
1 reference
A Kashiwagi
1 reference
H Takahashi
1 reference
H Ishikawa
1 reference
S Yoshida
1 reference
K Kazuta
1 reference
A Utsuno
1 reference
E Ueyama
1 reference
1 reference
Identifiers
1 reference